Grifols, the world’s third largest manufacturer of plasma-based therapeutics and a leader in immunohematology and transfusion medicine diagnostics, has been patiently developing a novel approach to treatment of AD, based on plasma exchange and replacement with donor human albumin.
While the incidence of cervical cancer is on the decline in the U.S., it is still a deadly disease, so prevention and early detection are essential.
While the healthcare industry is currently experiencing an oversupply of the lifesaving immune globulin therapy, with demand growing at 6 percent to 8 percent a year, is it possible another shortage looms large?
How do these infectious agents hitch a ride with passengers, and what role does screening play in containing the public health risk posed by international air travel?
A better understanding of Ebola, how it spreads and what’s being done to curb it will help to quell the fear over this massive outbreak that has now crossed international borders.
While the intravenous route has been the standard method of IG therapy for autoimmune and other neuromuscular disorders, recent studies show that the subcutaneous route is both as effective and more preferred by patients.
Healthcare industry stakeholders are increasingly using diagnosis-specific apps and educational gaming platforms to engage with patients, encourage compliance and even manage treatment options.
Medicine has come into the electronic age with telemedicine, which provides wider reaching care in an era when there is a projected doctor shortage.
There is no effective treatment for this devastating disease, but research is paving the way for better diagnostic methods and new therapies to prevent, slow or stop it.
Treatment advances over the past 40 years have transformed the lives of people with hemophilia, and more innovation lies ahead.
During the past two decades, regenerative medicine has made vast strides, with skin, cartilage and even organs being grown to cure complex and chronic incurable diseases, and this is just the beginning.
Thanks to breakthroughs in genome sequencing, personalized medicine is rapidly becoming more science than fiction. As experimental therapies are replaced with data-driven solutions, we may be closer than ever to the kind of patient-specific care that promises to revolutionize the way medicine is practiced.